This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Volatility Reigns Supreme on Wall Street: Top 5 Picks for June
by Nalak Das
We have narrowed our search to five U.S. corporate behemoths (market capital > $50 billion). These are: MMM, CI, UNH, XOM and COP.
Company News for June 1, 2022
by Zacks Equity Research
Companies in The News Are: AMZN, QCOM, UNH, AMC
Factors that Make UnitedHealth Group (UNH) an Attractive Bet Now
by Zacks Equity Research
UnitedHealth Group (UNH) continues to benefit from sustained top-line growth, a growing membership, and a strong cash position.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Veeva Systems (VEEV) Vault CTMS to Aid Clinical Trial Management
by Zacks Equity Research
Veeva System's (VEEV) Vault CTMS to streamline complex trial processes for more than 150 companies.
Are Medical Stocks Lagging Assertio (ASRT) This Year?
by Zacks Equity Research
Here is how Assertio (ASRT) and UnitedHealth Group (UNH) have performed compared to their sector so far this year.
Hologic (HOLX) Gets CE Mark for Fusion Molecular Assays
by Zacks Equity Research
Hologic's (HOLX) two new molecular assays monitor transplant patients for EBV and BKV.
Haemonetics (HAE) Gains on Procedure Recovery Amid Cost Woes
by Zacks Equity Research
A strong procedure recovery in the hospital business, the resilience of blood donors in blood centers, and rollouts of Persona technology and NexSys aid Haemonetics (HAE).
Medtronic's (MDT) New JV With DaVita to Expand Renal Care Line
by Zacks Equity Research
NewCo is expected to operate successfully, leveraging Medtronic's (MDT) capabilities as a healthcare technology leader and DaVita's deep expertise as a comprehensive kidney care provider.
Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now
by Zacks Equity Research
Investors are optimistic about Myriad Genetics (MYGN) owing to strong Q1 2022 results and growth in testing volumes.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
by Zacks Equity Research
Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.
IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern
by Zacks Equity Research
Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.
Abbott (ABT) Transcatheter Valve Devices' Study Data Favorable
by Zacks Equity Research
Abbott's (ABT) study data presented at EuroPCR 2022 reinforces the company's commitment to offering structural heart solutions, supported by clinical evidence that exceeds existing standards of care.
Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger
by Zacks Equity Research
Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi
by Zacks Equity Research
Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi have been included in this Analyst Blog.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $492.08, moving +1.31% from the previous trading session.
Top Stock Reports for Alphabet, UnitedHealth & Costco
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH), and Costco Wholesale Corporation (COST).
Here's Why Investors Should Retain Haemonetics (HAE) For Now
by Zacks Equity Research
Investors are optimistic about Haemonetics's (HAE) better-than-expected results and robust segmental performance.
Alcon (ALC) Signs EYSUVIS-Buyout Deal With Kala Pharmaceuticals
by Zacks Equity Research
The acquisition of EYSUVIS complements Alcon's (ALC) Systane family of eye drops offering, strengthening its treatment options for dry eye disease.
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock
by Zacks Equity Research
Investors are optimistic about Exact Sciences (EXAS) on impressive Q1 results and a bullish 2022 outlook.
Align Technology (ALGN) to Offer Asana Smiles With New Pact
by Zacks Equity Research
Align Technology's (ALGN) new partnership will give doctors access to an alternative that helps reduce manual processes and creates a clear view of Invisalign treatment workflows.
Why UnitedHealth Group (UNH) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Align Technology (ALGN) Debuts Invisalign Outcome Simulator Pro
by Zacks Equity Research
The next-generation of Align Technology's (ALGN) advanced patient communication tool will help patients see their potential new smile after Invisalign treatment.
LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients
by Zacks Equity Research
LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.